

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 2,5mg | 360 pills | A$0.66 | A$319.09 A$239.32 Best Price | |
| 2,5mg | 270 pills | A$0.89 | A$319.09 A$239.32 | |
| 2,5mg | 180 pills | A$1.11 | A$265.90 A$199.43 | |
| 2,5mg | 120 pills | A$1.33 | A$212.72 A$159.54 | |
| 2,5mg | 90 pills | A$1.55 | A$186.12 A$139.59 | |
| 2,5mg | 60 pills | A$1.77 | A$141.80 A$106.35 | |
| 2,5mg | 30 pills | A$2.22 | A$88.61 A$66.46 | |
| 5mg | 360 pills | A$1.11 | A$531.83 A$398.88 | |
| 5mg | 270 pills | A$1.37 | A$493.42 A$370.07 | |
| 5mg | 180 pills | A$1.71 | A$410.69 A$308.02 | |
| 5mg | 120 pills | A$1.82 | A$289.54 A$217.16 | |
| 5mg | 90 pills | A$2.22 | A$265.90 A$199.43 | |
| 5mg | 60 pills | A$2.44 | A$194.99 A$146.24 | |
| 5mg | 30 pills | A$2.88 | A$115.21 A$86.41 | |
| 10mg | 270 pills | A$4.43 | A$1,595.56 A$1,196.67 Popular | |
| 10mg | 180 pills | A$4.88 | A$1,170.07 A$877.55 | |
| 10mg | 120 pills | A$5.54 | A$886.41 A$664.81 | |
| 10mg | 90 pills | A$5.98 | A$717.99 A$538.49 | |
| 10mg | 60 pills | A$6.43 | A$514.10 A$385.58 | |
| 10mg | 30 pills | A$6.65 | A$265.90 A$199.43 |
Disclaimer: This information is for adults seeking general information about Bystolic (nebivolol) in Australia. It is not a substitute for medical advice. The need for a prescription may vary by local rules. If you have questions about your health, consult a healthcare professional.
Bystolic is nebivolol, a beta-1 selective adrenergic blocker (a beta-blocker) used to treat hypertension. It belongs to a class of medicines that work on the heart and blood vessels to lower blood pressure and ease the workload on the heart.
In simple terms, nebivolol primarily targets beta-1 receptors in the heart. By dampening the heart’s response to stress signals, it slows the heart rate and reduces the force of contraction. The result is lower blood pressure and less strain on the heart during daily activities and during exercise.
Nebivolol is often formulated as tablets taken by mouth. In Australia, the medicine may be prescribed by a clinician and supplied by an online pharmacy following local guidelines. The exact dose and duration depend on individual factors such as blood pressure, heart rate, kidney function, and tolerance to the medicine.
In addition to its heart-rate reducing effect, nebivolol has a relatively distinctive feature among beta-blockers: it can promote the release of nitric oxide (NO) from the lining of blood vessels, which helps to widen the arteries. This vasodilating property can contribute to blood pressure reduction and may influence how patients feel during treatment. Your clinician will weigh these characteristics against any other medical conditions you have.
Because Bystolic is a prescription medicine in many settings, it is important to use it under professional guidance. Sudden changes in dose or stopping the medicine abruptly can cause changes in blood pressure or heart rhythm. If you have questions about taking this medicine, talk with a pharmacist or doctor.
Nebivolol is approved for the treatment of hypertension in adults. It may be prescribed alone or together with other antihypertensive medicines to help lower high blood pressure.
In routine practice, nebivolol is chosen for patients where a selective beta-1 blocker is preferred due to certain lung, metabolic, or circulation considerations. It is generally considered after evaluating a patient’s heart rate, rhythm, and other medications they may be taking.
As with other antihypertensive therapies, the goal is to achieve a blood pressure in a safe range while preserving or improving symptoms and daily functioning. Ongoing monitoring by a clinician is important to ensure the treatment remains appropriate as health conditions or medications change.
Some patients may experience a slower rise in blood pressure during physical activity or a reduction in standing-related lightheadedness as the medicine takes effect. Your clinician will discuss expected timelines for response and what to expect as therapy begins or is adjusted.
Always follow the dosing plan provided by your clinician and report any persistent dizziness, swelling, fatigue, or unusual symptoms. If your blood pressure readings remain high or you feel unwell, contact a healthcare provider promptly for advice. If there is a concern about pregnancy, breastfeeding, or other health changes, seek medical guidance before continuing or adjusting therapy.
Beyond its primary role in lowering blood pressure, clinicians may consider nebivolol for other conditions on an individual basis. Some physicians use beta-blockers to help manage certain heart rhythm issues, chest pain from ischemia, or after a heart attack, depending on the patient’s overall clinical picture. Nebivolol’s selective action and vasodilatory properties may influence decisions in specific scenarios.
In some patients, nebivolol is used as part of a broader strategy to reduce the heart’s workload when other medicines are not tolerated well. For example, if a patient needs a medication with a beta-blocking effect but has concerns about bronchospasm, a cardioselective agent may be preferred. These uses are considered on a case-by-case basis and should be discussed with a clinician.
Off-label use is guided by clinical judgement and available evidence. The safety and effectiveness of non-standard uses can vary, and not all healthcare settings will support such uses. If your clinician suggests a use outside standard indications, ensure you understand the rationale, potential benefits, and risks.
It is important to obtain care from a qualified prescriber who can tailor treatment to your health history and may adjust therapy over time. If you are considering any off-label use or combination therapies, ask about potential interactions or side effects and how to monitor your response to treatment.
Always report new symptoms or changes in health to your clinician. If you are uncertain whether a particular use is appropriate for you, seek professional advice before starting or continuing therapy with nebivolol.
Nebivolol blocks beta-1 receptors primarily in the heart. This reduces heart rate and the force of the heart’s pumping, which lowers blood pressure and lightens the heart’s workload.
A notable feature of nebivolol is its effect on blood vessel lining. It promotes the release of nitric oxide, a molecule that helps relax and widen blood vessels. This combination of heart-rate lowering and vessel widening can contribute to better blood flow and lower blood pressure.
In practical terms, this means nebivolol can help patients feel steadier and experience fewer symptoms related to high blood pressure, such as headaches or fatigue caused by elevated pressures. Individual responses vary, and some people may notice improvements in energy or exercise tolerance over time.
The beta-1 selectivity means the drug primarily affects the heart with less risk of triggering bronchospasm or wheeze than non-selective beta-blockers. However, no medicine is without risks, and the choice of therapy should be individualized for each patient’s health profile.
Overall, nebivolol reduces the heart’s demand for oxygen and work, which is central to controlling high blood pressure and supporting heart health. How quickly someone responds depends on the dose, body chemistry, and other factors such as concurrent medications or kidney function.
Pharmacologically, nebivolol is described as a highly selective beta-1 blocker with vasodilatory properties mediated through nitric oxide pathways. This combination distinguishes it from some older beta-blockers that primarily reduce heart activity without actively facilitating vasodilation.
In the body, nebivolol’s actions include decreased heart rate, reduced cardiac output, and dampened renin-angiotensin system activity. These effects contribute to lower systemic vascular resistance and improved blood flow. The NO-mediated vasodilation can modestly lower afterload and may influence how arterial resistance changes in response to exercise or stress.
Because nebivolol has multiple mechanisms, it can be considered in patients who require beta-blockade but also have issues where improved vascular tone would be beneficial. Clinicians consider these pharmacologic features alongside a patient’s lung function, metabolic profile, and other medications when planning therapy.
As with all beta-blockers, nebivolol can mask certain signs of low blood sugar and may interact with drugs that affect heart rhythm. It is important to take this medicine under medical supervision and to report any unusual symptoms, such as dizziness, fainting, or swelling, to a healthcare professional promptly.
The exact dosing plan for nebivolol should be determined by a clinician who knows your health history. A typical approach involves starting at a low dose and gradually adjusting based on blood pressure response and tolerance.
Nebivolol is usually taken once daily, with or without food. If you experience dizziness or lightheadedness on starting therapy, tell your clinician, as it may reflect a temporary adjustment period or require dose modification.
Tablet strengths vary; your clinician will choose a strength that aligns with your blood pressure and heart rate targets. If a dose is missed, take it as soon as you remember unless it is close to the time of the next dose. Do not double up to make up for a missed dose.
Do not stop nebivolol suddenly without medical advice. Abrupt withdrawal can worsen chest pain or cause blood pressure to rise quickly. If a decision is made to discontinue the medicine, a clinician will plan a gradual taper.
Special populations may require adjustments. People with kidney impairment, older adults, or those taking other heart medicines may need lower starting doses or slower titration. Always follow the prescribing clinician’s guidance and report any new or worsening symptoms during dose changes.
Nebivolol is contraindicated in certain conditions where beta-blockade could be harmful. Severe bradycardia (very slow heart rate), second- or third-degree heart block without a functioning pacemaker, decompensated heart failure, or known hypersensitivity to nebivolol are examples where the medicine would typically not be used without careful consideration.
Patients with asthma or certain forms of chronic obstructive pulmonary disease may benefit from nebivolol due to its relative selectivity, but bronchospasm cannot be entirely ruled out. If wheezing or trouble breathing occurs, contact a clinician promptly.
Common safety considerations include monitoring for dizziness, fatigue, cold extremities, or swelling of the legs. Beta-blockers can mask some symptoms of low blood sugar in people with diabetes, so individuals who have diabetes should monitor their blood glucose and discuss symptom awareness with their healthcare provider.
In pregnancy, data on nebivolol’s safety is limited. The decision to use nebivolol during pregnancy should involve a careful assessment of maternal and fetal risks and benefits. If pregnancy occurs or is planned, consult a clinician to discuss options and alternatives. Breastfeeding considerations should also be discussed with a healthcare professional.
Nebivolol can interact with other medicines. Drugs that slow the heart or lower blood pressure further (for example certain calcium channel blockers or other antihypertensives) may enhance the blood pressure-lowering effect and cause dizziness or fainting. Your clinician will review your full medicine list to reduce this risk.
Non-prescription medications, herbal supplements, and alcohol can also affect blood pressure or heart rate. Communicate any supplements you’re taking, including over-the-counter products, to your pharmacist or clinician before starting nebivolol.
People with kidney disease or liver disease may require dose adjustments or more frequent monitoring. If you have a condition that affects kidney or liver function, discuss this with a clinician before starting nebivolol.
During procedures or anesthesia, inform the medical team that you are taking nebivolol. Some perioperative or interventional regimens may require adjustments to beta-blocker therapy to avoid instability in blood pressure or heart rhythm.
Regular monitoring of blood pressure and heart rate is important when starting nebivolol or adjusting the dose. Your clinician will determine how often to check these measurements and may request periodic blood tests to evaluate kidney function or cholesterol levels as part of a comprehensive cardiovascular risk assessment.
Engaging in a heart-healthy lifestyle supports medication efficacy. This includes a balanced diet rich in vegetables, fruits, and whole grains, moderate physical activity as advised by a clinician, maintaining a healthy weight, and avoiding tobacco products.
Be mindful of symptoms that warrant medical attention, such as persistent dizziness, fainting spells, chest pain, swelling in the ankles or feet, shortness of breath, or unusual tiredness. Seek urgent medical help if you experience sudden severe chest pain or trouble breathing.
Storage of nebivolol should be in a cool, dry place away from light. Keep medicines out of reach of children. Do not use outdated medicines or those no longer prescribed for you, and only take this medicine under the guidance of a healthcare professional.
When used long term, regular review with your clinician helps ensure the medicine remains appropriate. If a decision is made to stop nebivolol, a gradual taper is often advised rather than abrupt cessation to avoid rebound effects on blood pressure or heart rate.
| Drug | Primary use | Notable feature |
|---|---|---|
| nebivolol | Hypertension (and certain heart conditions) in adults | Beta-1 selectivity with nitric oxide–mediated vasodilation |
| metoprolol | Hypertension, angina, some arrhythmias | Common beta-1 blocker with cardiac selectivity; multiple formulations |
| atenolol | Hypertension, angina, certain rhythm disorders | Longer track record; often once-daily dosing |
| bisoprolol | Hypertension, heart failure with reduced ejection fraction in some settings | Cardioselective beta-1 blocker with gradual titration |
Bystolic is a beta-1 selective blocker, which means it has less effect on the airways than non-selective beta-blockers. However, it can still cause breathing issues in some people with asthma or COPD. Discuss your lung history with your clinician before starting nebivolol.
Blood pressure reduction is usually detectable within days to a few weeks, but the full effect may take several weeks. Your clinician will monitor your response and adjust the dose as needed.
If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not double up to make up for a missed dose. If you frequently forget doses, discuss a plan with your clinician.
Moderate alcohol consumption can affect blood pressure and heart rate. It is best to limit alcohol and discuss with your clinician how alcohol may interact with nebivolol in your situation.
Pregnancy safety with nebivolol has not been established in all scenarios. If you are pregnant, planning a pregnancy, or breastfeeding, talk to your clinician about potential risks and alternatives. Do not start or continue therapy without professional guidance.
Combination therapy is common in hypertension management. However, nebivolol can interact with other medicines that lower blood pressure or affect heart rhythm. Your clinician will review your full medication list to manage interactions and monitor for side effects.
Lightheadedness or dizziness can occur when starting nebivolol or adjusting the dose. Sit or lie down if you feel faint and contact your clinician, especially if the symptoms are persistent or severe.
Beta-blockers can mask some signs of low blood sugar in people with diabetes. If you have diabetes, monitor blood sugar closely and discuss symptoms with your healthcare provider, particularly when therapy starts or changes.
Many patients use nebivolol long term under supervision. Ongoing assessments by your clinician help ensure the treatment remains appropriate and safe. Report new symptoms or changes in health during long-term use.
Share your full medical history, including heart conditions, lung conditions, kidney or liver disease, electrolyte problems, diabetes, pregnancy plans, and all medicines you take—prescription, over-the-counter, and herbal. This helps reduce the risk of interactions and side effects.
Common side effects include fatigue, dizziness, or cold hands and feet. Seek medical help if you experience severe or persistent symptoms such as fainting, shortness of breath, swelling of the ankles, or chest pain. If you notice any signs of an allergic reaction, seek urgent medical attention.
Store at room temperature in a dry place away from light. Keep out of reach of children. Do not use medications that are past their expiry date. If you no longer need the medicine, discuss safe disposal with your pharmacist.
No. Stopping beta-blockers abruptly can cause a rebound rise in blood pressure or heart rate, and may worsen symptoms. If you need to stop, your clinician will plan a gradual taper to lessen the risk of adverse effects.
Some people notice changes in exercise tolerance as the body adjusts to the medication. This varies a lot between individuals. If you are an active athlete or have specific exercise goals, discuss them with your clinician to tailor dosing and monitoring.
Inform the surgical or anesthesia team that you are taking nebivolol. Some procedures or anesthetic medications may interact with beta-blockers, requiring adjustments. Do not stop therapy without medical advice before surgery.
Yes, some supplements can influence blood pressure or heart rate. Tell your clinician about any vitamins, minerals, or herbal products you use so they can assess potential interactions with nebivolol.
The duration of therapy depends on your blood pressure control, heart health, and tolerance. In many cases, nebivolol is used long term under ongoing medical supervision. Regular check-ins with your clinician are important to determine the best plan for you.
Swelling and weight changes can be related to heart function, fluid balance, or other medicines. Report these changes to your clinician, as they may indicate a need for dose adjustment or evaluation for other conditions.
14–21 days. Free from A$285.95 .
5–9 days. A$42.89
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
